Search…

Fuhong Hanlin: The first patient in China to receive treatment with HLX701 in combination with cetuximab and chemotherapy for advanced colorectal cancer in a phase 1b/2 clinical study.

26/03/2026

(Fosun Pharma) announced that recently, the first patient in China received treatment with HLX701 in combination with cetuximab and chemotherapy for the 1b/2 phase clinical study of advanced colorectal cancer.

Latest

3 m ago

Shanghai International Energy Trading Center: The daily price limit for the EC2703 contract of the freight index is 20%, the margin requirement ratio for hedging position trading is 22%, and the margin requirement ratio for regular position trading is also 22%.

3 m ago

Shanghai International Energy Trading Center: Since the listing of the EC2703 contract of the self-collected freight index futures, the maximum number of open trades for non-futures corporate members, overseas special non-broker participants, and customers on the day of the contract is 50 lots.

4 m ago

ST Zhengping: The company's stock has been suspended for verification since March 27th.

4 m ago

Fullerite: net profit of 981 million yuan in 2025, a year-on-year decrease of 2.59%

4 m ago

Turkish Minister of Trade: Turkey has withdrawn its opposition and will not obstruct the inclusion of the Agreement on Facilitation of Investment Promotion in the Development in the framework of the World Trade Organization.

See all latest

+852 - 60190728

gmteight@futurecultural.com

Customer Support

Commercial Services